Banville Law Comments On Low Testosterone Lawsuit Alleging Heart Attack

September 16, 2015 – – Banville Law comments on a low testosterone lawsuit filed over the fatal heart attack of a Delaware man. The man’s son, who filed a complaint against the makers of AndroGel and Axiron in April of 2014, alleged that the serious side effects of the drug caused his father’s fatal heart attack.

According to the complaint, the man’s father passed away on April 17, 2012 due to a massive heart attack. The victim was first prescribed AndroGel just 6 months earlier at age 58 and had no previous history of heart disease. After being prescribed this “Low T” treatment, over the course of just half of a year, he used AndroGel and then switched to Axiron shortly before passing away from a heart attack.

The complaint seeks damages from the manufacturers of AndroGel and Axiron: AbbVie Inc., Abbott Laboratories, and Eli Lilly and Company. The plaintiff alleges that, through specific advertisements for low testosterone treatments, the victim was enticed to ask his doctor for a prescription. Additionally, the lawsuit claims that the manufacturing companies used a combination of untrue and misleading statements which presented the products as safe ways to raise testosterone levels.

This case joins many others filed in the U.S. District Court for the Northern District of Illinois on behalf of men and their families across the nation who also allege that their testosterone therapy medications caused serious health complications, such as strokes, blood clots, heart attacks, and even death. Many complaints also suggest that warnings associated with these products are not comprehensive enough.

In late March of 2014, a motion was filed by several plaintiffs to centralise all low testosterone therapy litigation before a United States District Judge, creating a Multidistrict Litigation or MDL. MDL No.2545 was initiated in the summer of 2014, with Honorable Judge Matthew F. Kennelly presiding. Today, the MDL encompasses over 2,000 individual lawsuits all relating to the dangerous risks associated with a variety of testosterone therapy drugs.

Laurence Banville, Esq. of Banville Law is currently helping both individuals and families throughout the U.S. who wish to join the pending litigation by filing their own lawsuit. “The fact patterns you see in this specific lawsuit are similar to many others filed in this litigation. The unfortunate consequence is that many men have died and several others have long term injuries from heart attacks and strokes after taking low testosterone supplements,” said Banville, commenting on this new filing.

For more information on this release or testosterone lawsuits, please visit LowTestosteroneCase.com or contact Laurence Banville, Esq. at 917-809-6595.

###

Contact Banville Law:

Laurence Banville, Esq.
888-478-9711
info@banvillelaw.com
165 West End Avenue, #1H
New York, NY 10023
United States (US)

ReleaseID: 60004216